Clinical Trials Directory

Trials / Unknown

UnknownNCT05261256

Cardiac Impairments Following Pediatric Cardiotoxic Anti-cancer Treatment

Early Detection of Cardiac Impairments Following Cardiotoxic Anti-cancer Treatment During Childhood and Adolescence - A Feasibility Study

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Technical University of Munich · Academic / Other
Sex
All
Age
10 Years – 25 Years
Healthy volunteers
Accepted

Summary

This study aims at investigating the feasibility of recruitment and application of a method regarding early detection of subclinical changes in cardiac health after completion of acute cancer treatment during childhood and adolescence.

Detailed description

Cardiovascular late effects following treatment for pediatric cancer are problematic. Early detection of subclinical changes is hardly possible using conventional diagnostic methods, but seems to be feasible during physical strain (exercise stress echocardiography). This feasibility study examines as main objective the recruitment strategy and investigation method in 10-25-year olds in the first and fifth year after the end of acute anti-cancer therapy (n=40 participants with a history of childhood cancer and n=40 control subjects). The heart function is examined by means of exercise stress echocardiography and spiroergometry in comparison with healthy age- and gender-matched control subjects. Secondary aims are the evaluation of aditional echocardiography markers and levels of physical activity.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTExercise stress echocardiographyStudy participants perform an exercise stress echocardiography on a semi-supine bicycle ergometer using using a continuous incremental bicycle protocol with a work rate increment every 3 minutes according to gender and weight.

Timeline

Start date
2022-02-01
Primary completion
2024-10-31
Completion
2024-12-31
First posted
2022-03-02
Last updated
2023-12-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05261256. Inclusion in this directory is not an endorsement.